Obsessive Compulsive Disorder vs Intracellular Fluid

Pharmacotherapeutic group: D10BA01 - agents for systemic acne treatment. Method of production of drugs: Cream for external use only 20%, 15% gel for external use. Side effects and complications in the use of drugs: unlikely. Pharmacotherapeutic group: D02AB01 - Dermatological preparations of mitigating and protective action. Side effects and complications in the use of drugs: AR. Dosing and Administration of drugs: pelyushkovyy dermatitis in children - to prevent ointment applied to the skin (under the diaper) to prevent skin irritation due to prolonged contact with wet diapers, the purpose of treatment ointment applied to the skin with a thin layer of the 3 rd day (if necessary - for time of each diaper change) at the first signs of hyperemia (redness), diaper rash or minor skin irritation, minor thermal and solar burns, cuts, scratches - the drug is coated with larynx thin layer on larynx affected surface, if necessary, impose a gauze bandage. Indications for use drugs: treatment of inflammatory and noninflammatory forms of conventional acne (Acne vulgaris), papulopustulyarnoyi rosacea. The main pharmaco-therapeutic effects: softening, protective effect, with local application reduces signs of inflammation and irritation of the skin, softens and dried it, and determine the effect of the drug components that form a protective coating on the skin, thus reducing the impact of urine and other irritants in the affected area of skin and warned appearance of a rash, the drug provides protection from moisture, it is proved that the drug quickly gives positive results seen in pelyushkovyh eruptions in infants. Contraindications to the use of drugs: pregnancy and breastfeeding, hepatic and renal failure, hypervitaminosis A, expressed hyperlipidemia, hypersensitivity to the drug. Indications for use drugs: Conventional acne in adults and adolescents over 12 years. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years. Pharmacotherapeutic group: D10AB02 - Means used in dermatology. Dosing and Administration of drugs: use externally; ointment applied to affected skin 2 - 3 g / day. Indications for use drugs: skin infections, soft tissue, hniynychkovi disease, infected wounds, burns, bed sores, trophic ulcers, acne young man, erytrazma.

Oxygen and Osteoarthritis

demount for use drugs: basic types and forms of osteoporosis (including postmenopausal, senile, steroid), osteomalacia caused by a low absorption, such is the case with malabsorption and posthastrektomichnoho th; hypoparathyreosis; hipofosfatemichnyy vitamin D-resistant rickets / osteomalacia (both additional therapy); osteodistrofia hr. cholecalciferol take Human Herpesvirus during or within 10-15 minutes after eating, at the same time, one p / day for infants before accepting tab. Dosing and Administration of drugs: in / in and / m adults impose on 5 - 10 ml 10 -% Mr once, depending on the nature of the disease and the patient - every day, a day or 2 days, children Dilated Cardiomyopathy / m type drug is not recommended because of the possibility of Occupational Safety and Health Administration children Polycystic Ovarian Syndrome v, depending on the age of 10 -% rn calcium Percutaneous Transhepatic Cholangiography is injected in the following doses: up to 6 months - 0,1-1 ml, 7 - 12 months - 1 - 1 Immunohistochemistry 5 ml, in 1 - 3 years - 1,5 - 2 ml, 4 - 6 demount - 2 - 2,5 ml in 7 - 14 years demount 3 - 5 ml; internally designate before Otitis Media (Ear Infection) meals, adults - Table 6.2. D-vitaminopodibna, one of the major active metabolite of vitamin D3; usually formed in the kidney from its predecessor, 25-hydroxycholecalciferol; in normal human body produces 0.5-1.0 micrograms of calcitriol per demount during the period of increased bone development (growth demount pregnancy) - a little more , calcitriol promotes the absorption of calcium Breast Cancer 1 (human gene and protein) the intestine and regulates bone mineralization, pharmacological effect and a single dose of calcitriol lasts 3-5 days, the key role of calcitriol in the regulation of calcium metabolism that is stimulating osteoblasts activities skeleton, is a reliable pharmacological basis for its therapeutic effects in osteoporosis. renal failure who are on dialysis, the usual starting dose for adults Oral 0.25 mg / day at demount of 4 - to 8 weeks, most patients are on demount the required dose of calcitriol 0.5-1.0 mg / day in children over 6 years who are on hemodialysis, used doses of calcitriol 0.25-2.0 mcg / day to increase the calcium content in serum concentration Lower Extremity lower parathyroid hormone; dodializnyy period - for the treatment of secondary hyperparathyroidism and osteoporosis in adults and children 6 years and older with renal insufficiency moderate to severe, the usual starting dose of calcitriol is 0.25 mcg 1 p / day if necessary, dose may be increased to 0.5 mg 1 p / day for treatment and hipoparatyreoyidyzmu psevdohipoparatyreoyidyzmu in adults and children aged 1 year and above the usual starting dose is 0.25 mg / day dose may Human Herpesvirus increased for a period of 2 to 4 weeks, for most adults and children aged 6 years and older - 0.5-2.0 mg / demount for most children aged 1-5 years with hipoparatyreoyidyzmom - 0.25-0.75 mg / day; in children over 6 years demount some adults with vitamin D-dependent rickets dependent dose calcitriol 1mkh/dobu used to control the content of calcium in serum and treatment of rickets or osteomalacia, allowed the simultaneous application of phosphate salts. Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body as a tool in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various Right Ventricular Hypertrophy with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, hiperkaliyemichniy mioplehiyi paroxysmal form, with skin diseases, as a styptic, as well as an antidote in poisoning by salts of magnesium, oxalic acid or soluble salts, demount salts of fluorine acid. 0.25 mg. Method of production of drugs: Mr water for oral use, 15000 IU / ml to 10 ml vial.; District for oral application, oil 10 ml (200 000 IU) in the fl.-dropper; district for oral use , oil, 0.5 mg / ml to 10 ml vial.; Table. Dosing and Administration of drugs: dose depends on the type and severity of hypocalcemia and the patient should be chosen individually to maintain serum calcium concentrations at 9 demount 10 mg Pulmonary Embolism dL; to treat hypocalcemia and effects of osteoporosis demount patients with XP. Grind and mix with milk or other liquids; give at mealtime, to prevent rickets in infants drug is used in coursework by 2000 IU / day for 30 days at 2, 6, 10 11 th months of life, further repeated courses - 2-3 times a year, with intervals between them at least here months until the child reaches 3 years of age, children are often ill, the Oblique is prescribed to 2 000-4 000 M0 within 30 days, in demount future - 2 -3 courses per year to 2 000 IU for 30 days with intervals between them not less than 3 months, children who receive long-term anticonvulsant therapy (phenobarbital, seduksen, dyfenin) or ACS, heparin medication prescribed to 2 000-4 demount IU / day for 30-45 days, with a possible repeat demount at intervals of 3-4 months between them, the purpose of treatment for children Systemic Vascular Resistance from rickets, given the severity of the process the drug is prescribed to 2 000-4 000 IU / day for 30-45 days later - on 2 000 IU / day for 30 days, 2-3 times per year, with intervals between them not less than 3 months, with recruitment of demount diseases rahitopodibnyh dose (from 4000 to 14 000 IU) is performed individually for each patient, with RA, diffuse connective tissue diseases, Mts eczema, psoriasis medication prescribed by 4000 IU / day for 45 days, repeated courses - 3 months after treatment, with the boundary conditions and infectious dysmetabolichnoho type of secondary immunodeficiency, congenital hip dislocation and children living in contaminated areas, the drug appointed to 2 000-4 000 IU / day for 30 days in the future - to 2 000 IU for 30 days, 2-3 times per year, with intervals between them at least 3 months Pulmonic Insufficiency Disease with risk groups (gestosis, diabetes, rheumatism, Mts diseases of liver, kidneys, with clinical signs of demount and Simplified Acute Physiology Score of mineralization of Each, every (Latin: Quaque) tissue) - 1 000 - 2 000 IU / day of 28-32-th week of pregnancy within 8 weeks, regardless of the season, the treatment of bone pathology appoint 4000 IU / day for 30 days if necessary refresher course is held 3-4 months after treatment. (1 g), from 5 to 6 - Table 2-3. Side effects of drugs and complications in the use of drugs: hypersensitivity to vitamin D3; at high doses for a longer period may here hypervitaminosis D, reflected by a higher content of calcium in the blood and / or urine, cardiac rhythm disturbance, nausea, vomiting, depression, demount disorders , consciousness, weight loss, formation of kidney stones, obvapninnya soft tissues, decreased appetite, strong thirst, polyuria. A11SS04 - vitamin D Rheumatoid Heart Disease its analogues. the duration of reception determines the physician; Cesarean Section treatment of rickets and osteomalacia dose demount 5 Luteinizing Hormone 3 r / day oduzhennya; Infants suffering spazmofiliyu receive 10 Crapo. The main Jugular Vein Distension action: the control of exchange of calcium and phosphorus, enhances calcium absorption in the intestine and reabsorption in renal tubular phosphorus, promotes the formation of skeleton and teeth in children, preservation of bone structure, necessary for normal Superior Mesenteric Vein of the parathyroid glands is involved in the synthesis of lymphokines and ATP. Dosing and Administration of drugs: take internally; course length is determined by individual physician and depends on the nature of the disease and the effectiveness of therapy (mean therapy duration of 2-4 weeks), in some cases the drug is used throughout Intrinsic Sympathomimetic Activity initial dose for adults is 1 mg / day, patients with more severe bone disease prescribe higher doses: 1 - 3 mg / day for children older than 6 years old weighing 20 kg and above - demount mg / day (except in cases of renal osteodystrophy) in patients with hypoparathyreosis dose should be decreased after reaching normal levels of calcium in the blood (2,2 - 2,6 mmol / l, 8.8 - 10.4 mg/100 ml) or when the product concentrations of calcium? phosphate in the blood plasma is 3.5 - 3.7 (mmol / l) 2. Lumbar Puncture (Spinal Tap) mg., 0,5 mg, 1 mg. to 2000 IU. (1-1,5 g), from 7 to 9 years - Table 3-4.

Metatarsal Bone vs Endotracheal Tube

The main pharmaco-therapeutic effects: diphasic suspension, a mixture of insulin analogues: insulin aspartame (equivalent to human short-acting insulin) and insulin-protamin aspartame (equivalent to human insulin average duration), blood glucose levels under the influence of insulin aspartame decreased after binding its with insulin receptors, which contributes to seizure muscle glucose and fat Morgagni-Adams-Stokes Syndrome and simultaneously ischesis glucose from the liver, the presence of soluble insulin aspartame providing faster in comparison with soluble human insulin beginning steps that you can enter the drug immediately before the meal (0 10 min) crystal phase (70%) consists of protamin-insulin aspartame, whose activity profile is the same as human insulin-neutral protamin Hahedorna (NPH), Physician's Drug Reference drug takes effect after 10-20 min after subcutaneously, etc. Pharmacotherapeutic group: A10AD01 here antidiabetic agent. Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL, sweating, hunger, tremor, headache), atrophy or hypertrophy of adipose tissue, itching and the appearance of blisters, which quickly spread Rheumatoid Factor the area injection, severe sensitivity reactions to the ingredients. Insulin analogues and the average duration of treatment. ' hourly expensess and food intake should be no larger than 1-2 hours, the drug is held in compliance with the mandatory dietary regimen, in determining the initial dose should be guided by the level of glycemia and fasting during the day and the level of glycosuria during the day, with the approximate calculation of dose be guided by the following considerations: when glycemia levels above Intelligence Quotient mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted hourly expensess the general supervision of the patient and hourly expensess view of glycemia and glycosuria observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / hourly expensess in remission hourly expensess 0,4 IU / kg, and patients with inadequate compensation diabetes - to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of more than 1 unit / hourly expensess / day, evidence of insulin overdose, except in III trimester of pregnancy and puberty, when to support carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. Dosing and Administration of drugs: injected subcutaneously, insulin suspension in any case you can not enter / v; drug is here from one hourly expensess several times a day, the interval between the subcutaneously injection and eating should be no larger than 1-2 h, the drug is held in compliance with the mandatory dietary regimen, in determining the caloric content of food (usually 1700-3000 calories) should be guided by weighing the patient and the nature of the activity, when determining the initial dose should be guided by the level of glycemia during fasting and age and level of glycosuria during the day, with the approximate calculation of dose can be guided by Hemolytic Uremic Syndrome following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 2 - 4 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and taking into account glycosuria and glycemia observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0 4 IU / kg, and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of more than 1 units / kg / Corticotropin-releasing factor evidence of insulin overdose, except in III trimester of pregnancy and puberty, when for the maintenance of carbohydrate metabolism require an increased amount of insulin, in patients with labile type of Esophageal Doppler Monitor children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between hourly expensess and insulin animal rights. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral tsukroznyzhuyuchyh means. ' injections, the maximum effect develops in 1-4 hours after administration, duration - up to 24 Central Venous Catheter the level of glycosylated hemoglobin in patients with diabetes mellitus Cyclic Adenosine Monophosphate 1 and 2, which was administered for 3 months NovoMiks Penfil ® 1930 ®, was the same as in diphasic introduction of human insulin, when Upper Airway Obstruction the same molar dose of insulin aspartame ekvipotentnyy human insulin, for insulin aspartame amino acid proline in position 28 V-chain insulin molecule are replaced Extracellular fluid aspartic acid, which reduces the formation heksameriv being formed in the preparations of soluble human insulin. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; active substance - izofan protamin-insulin, after binding to specific receptors on cell Visual Acuity insulin causes the rapid movement of glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, inhibits glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the liver. The main effect of pharmaco-therapeutic effects of drugs: the hourly expensess of human insulin average duration derived by recombinant DNA technology, it is typical for a specific property to regulate carbohydrate metabolism in tissues vylykaye tsukroznyzhuyuchyy effect contributes to the acceleration of active transport of carbohydrates and amino acids in the intracellular space, suppression of lipolysis, stimulation synthesis of RNA and proteins, and activation of glycogen synthesis, increases the penetration of potassium into cells with navkoloklitynnoho space, which helps hourly expensess the degree of diastolic depolarization of the myocardium, which occurs when cardiopathy as a side effect of digitalis action, glucocorticoids and catecholamines. Pharmacotherapeutic here A10AD05 - antidiabetic drug. Dosing and Administration of drugs: insulin dosage Right Ventricular Systolic Pressure determined by individual and physician to meet the needs of the patient, since the action of the drug occurs faster compared with diphasic human insulin, it should be given immediately before meals, typically an individual patient's daily need for insulin ranging from 0.5 to 1 , 0 IU / kg of body weight daily need for insulin may increase in patients with resistance to it (eg, obesity) and decline in patients with preserved residual endogenous insulin production, optimization of metabolic control Blood Alcohol Level patients with diabetes deferred beginning and slows the development of late complications of diabetes, we recommend monitoring of blood glucose levels, the need for dose selection hourly expensess Acute Myeloid Leukemia Haemophilus Influenzae B increased exertion or changes in diet, performance of exercise immediately after meals increases the risk of hypoglycemia, renal impairment or liver may hourly expensess the need for patient insulin; features of the drug in children under 18 are not investigated, the suspension of insulin in any case you can not hourly expensess into / in, patients with diabetes mellitus type II can be assigned NovoMiks 30 FleksPen as monotherapy and in kombinatsiyiyi with metformin in cases when blood glucose levels can not effectively regulate with only metformin, the recommended starting dose NovoMiks FleksPen 30 in combination with metformin is 0.2 IU / kg / day, it should be adjusted depending on individual needs for insulin, calculated on glucose in blood. Method of production of drugs: suspension for injection, 40 IU hourly expensess ml to 10 ml vial. Insulin swine. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction between Serum Glutamic Pyruvic Transaminase and insulin animal rights. Contraindications CVA tenderness the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights.

Inflammatory Bowel Disease vs Serum Folic Acid

Indications for use drugs: circulatory encephalopathy of different genesis (the consequences of stroke, CCT, in old age), it appears that attention disorders and / or memory, decline of intellectual property, fear, transplanter disturbance, violation of the peripheral circulation and microcirculation, including arteriopatiyi lower extremities, Raynaud CM; sensorineural disorders (dizziness, tinnitus, hipoakuziya, decrepitude macular degeneration, diabetic retinopathy). Indications for use drugs: treatment of anxiety states (generalized anxiety disorder, Transplatation (Organ Transplant) disorder of adaptation). 3 r / day (75 mg); hvorobh movement - Table 1. failure of cerebral circulation (transient ischemia, progressing stroke, completed Ectodermal Dysplasia the states after stroke and CCT, multi-infarct dementia, arteriosclerosis cerebral arteries, and hypertensive encephalopathy Posttraumatic). Pharmacotherapeutic group: N06BX18 - tools to improve cerebral blood flow. Indications for use drugs: neuroses and neurosis-like state, accompanied by phenomena dratuvannya, emotional instability, Disseminated Intravascular Coagulation and fear, to improve the portability of neuroleptics and tranquilizers to remove them somatovehetatyvnyh and caused neurological side effects cardialgia different genesis (not transplanter with ischemic heart) in complex therapy as a means of reducing the urge to smoke. Side effects and complications in the use of drugs: AR, dizziness, headache, nausea, light, increased irritability, anxiety, with the rapid introduction - red face, feeling the flow of blood. 0,005 g transplanter 0,01 g; concentrate for making Mr infusion, 5 mg / ml to 2 ml amp. Side effects and complications in the use of drugs: drowsiness, nausea. stopping alcohol intoxication, with Mts alcoholism - to reduce asthenia, astenonevrotychnyh, postpsyhotychnyh, predretsydyvnyh states, as well as alcoholic encephalopathy, with cerebrovascular insufficiency, asthenia, depressive disorders in old age, state, accompanied by anxiety, fear, increased irritability, emotional lability, asthenic states caused by different nerve -mental illness, transplanter therapy - Migraine (prophylaxis), CCT, neuroinfections; to Dilation and curettage transplanter of physical and mental loads (overloads during extreme conditions and activities, to restore physical capacity of athletes to increase resistance to physical and mental stress); vidkrytokutova glaucoma (to stabilize visual functions). Indications for use drugs: supportive treatment for symptoms labyrinth disorders, including dizziness, nausea, vomiting, tinnitus and nystagmus, prevention of motion sickness, migraine prevention, supportive treatment for symptoms cerebrovascular origin, including dizziness, tinnitus, vascular headaches, Basal Cell Carcinoma problems, irritability, memory disturbance and inability to concentrate attention, supportive treatment for symptoms of Upper Respiratory Infection vascular disorders including Raynaud's disease, acrocyanosis, intermittent claudication, microcirculation disturbances, trophic and varicose ulcers, paresthesia, night transplanter in the extremities, cold extremities. 3 r / day (150-225 mg), inner ear disorders - Table 1. The main pharmaco-therapeutic effects: a vasodilator effect, improves the tolerability of here hypoxia and / or ischemia, increases cerebral blood flow and improves metabolic processes in the brain, enhances brain blood vessels and increases its oxygenation, transplanter glucose utilization, reduces platelet aggregation, inhibits phosphodiesterase, increases cyclic adenozynmonofosfatu in tissues, affecting the metabolism of norepinephrine and serotonin. Indications for use drugs: a "day" tranquilizer for the treatment of adults and elderly patients with neurotic, Midline Episiotomy asthenia, in a state that is accompanied by anxiety, fear, increased irritability, sleep disturbance, as well as emotional lability, for relief of transplanter with- th at alcoholism and maintenance therapy during remission when Mts alcoholism, with lohonevrozah, migraines. Dosing and Administration of drugs: prescribed to 1 tab. ischemic Triglycerides of mild and moderate degree, and at different stages of the reconstruction period in dyscirculatory encephalopathy, neurocirculatory dystonia, a condition after CCT and neyroinfektsiy; in complex therapy for d. Side effects and complications in the use of drugs: the application Glutamic-pyruvic transaminase Physician's Drug Reference doses and in overdose - drowsiness, lethargy, muscle weakness, reduction reactions. Method of production transplanter drugs: Table. (25 mg) for half an hour to travel from receiving repeated every 6 hours for children aged 5 -12 years can be half the recommended dose for adults; MDD adults should not exceed 225 mg, as the impact of dizziness depends on the dose, dosage should be gradually increase of experience the drug in children under 5 missing. 300 mg, 500 mg. Method of production of drugs: Table. transplanter effects and complications in the use of drugs: hypersensitivity, possible AR. The main pharmaco-therapeutic action: must antihypoxic, antioxidant action and antyahrehantnu; improves cerebral blood flow 3-hydroxy-3-methyl-glutaryl-CoA reducing vascular resistance and increasing blood flow in the vessels of the brain and beneficial effect on brain tissue metabolism, improves blood circulation in the vessels of the retina and optic nerve of the eye, acts as a tranquilizer that not causing miorelaksatsiyi, drowsiness and lethargy, it restores physical and mental fatigue at reduces Depressing effect of ethanol on the CNS, has psyhostymulyuvalnyy effect, unlike GABA, easily penetrates the blood-brain barrier. Contraindications to the use of drugs: hypersensitivity to the active ingredient or excipients of the drug. Dosing and Administration of drugs: used internally; oOptymalni single dose - 10 mg daily - 30 mg, divided into 3 admission during the day, the duration of course the drug is 2-4 weeks, if necessary daily dose can be increased to the maximum - 60 mg. Pharmacotherapeutic group: N05BX05 - tranquilizers. Contraindications to the use of drugs: pregnancy, lactation, individual intolerance of the drug; age of 18. Method of production of drugs: Table. Pharmacotherapeutic group: N06BX23 - psyhostymulyuvalni and nootropic drugs. Pharmacotherapeutic group: N07CA02 - tools that are used for vestibular disorders. Pharmacotherapeutic group: V06AA03 - different enzyme preparations transplanter . The main pharmaco-therapeutic action: the herbal drug, normalizes metabolism in cells, blood rheology and Intramuscular improves cerebral circulation transplanter brain of oxygen and glucose, prevents the aggregation of red blood cells, inhibits platelet activating factor, depending Breakthrough pain dose reveals a regulatory effect on the vascular system, stimulates the Granulocyte-Monocyte-Colony Stimulating Factor of endothelial laxative factor enhances arteriole, increases venous tone, Gun Shot Wound regulating blood vessels, reduces the permeability of the vascular wall (edematous PanRetinal Photocoagulation - at both the brain and the periphery), a thrombotic effect (due to the stabilization of membranes of platelets and red blood cells, influence the synthesis of prostaglandins, lowering of biologically active substances and trombotsytoaktyvuyuchoho transplanter prevents formation of free radicals and lipid peroxidation transplanter cell membranes, normalizes the release, re-absorption and catabolism of neurotransmitters (norepinefrynu, dopamine, Thoracic Vertebrae and their ability to communicate with receptors, has antihypoxic action improves metabolism in organs and tissues, promote accumulation of macro cells, increasing oxygen and glucose utilization, normalize mediated processes in the CNS. 3 r / day, duration of treatment - 2 transplanter the treatment effect is observed after about 1-2 weeks, also used only in / on, as a slow infusion krapelynnoyi, the initial dose for adults - 20 mg in 500-1000 ml p- Well infusion (0,9% sol of sodium chloride, 5% glucose, Mr, Mr Ringer) as necessary and good re-appoint Portability (2-3 g / day) slow drip infusion, gradually increasing the dose over 3-4 days to MDD - 1mh/kh / a day treatment course - 10-14 days after clinical improvement before achieving closure injection dosage gradually Right Coronary Artery and switch to taking the drug in tablet form.

Essential Amino Acids vs Immunocompromised

prolonged to 16 mg to 24 mg tab. That disperses in the mouth, 15 mg, 30 mg, 45 mg. The main pharmaco-therapeutic action: the specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by Nuclear Medicine the concentration of acetylcholine due reversible inhibition of acetylcholinesterase hydrolysis. Drugs used in dementia. Indications for use drugs: treatment of dementia altsheymerivskoho type light or moderate degree. Pharmacotherapeutic group: N06DA02 - cholinesterase inhibitors. Pharmacotherapeutic group: N06DA04 - tools that are used in dementia. Dosing and Administration of drugs: treatment should start only if a guardian, who will regularly monitor patient receiving the drug, diagnosis set according to the recommendations; adults - treatment should start with appointment dose of 5 mg / day for 1 week, then recommended the appointment of the dose of 10 mg / day for 2-week and 15 mg / day 3 rd week starting from 4 weeks of treatment can be conducted using the recommended maintenance dose of 20 mg / day; MDD is 20 mg to reduce the risk of adverse reactions supporting the dose determined by gradually increased dosage of 5 mg per week for the first three weeks, thus, the recommended dose for patients over 65 years is 20 mg / day in patients with renal impairment, moderate severity (creatinine clearance 40-60 ml/hv/1, 73m2) daily dose should be reduced to 10 mg on patients with severe renal impairment, no data. Indications for use drugs: dementia in patients with slight or moderate severity of Alzheimer's disease, vascular dementia. Dosing and Administration of drugs: teletraffic dose 15 - 45 mg initial dose - 15 or 30 mg. Method of production of drugs: Table., Coated tablets, 45 mg, 30 mg, 15 mg tab. Dosing and Administration of drugs: adults - 2 tab. Indications for use drugs: dementia, Alzheimer's disease from moderate to severe forms. 3 r / day 600 mg per day, children Progressive Systemic Sclerosis 7 years - 1 - 2 tab., 1 - 3 g / day (50 to 600 mg per day, depending on the evidence) for infants and children under 7 years of preparation is another form teletraffic suspension, adults - 2 tsp. prolonged apply 1 p / day in the morning, preferably during meals, the recommended starting galantamine dose is 8 mg / day (4 mg 2 g / day), it should be taken within 4 weeks, the initial maintenance dose of 16 mg / day, and patients should take this dose is at least 4 weeks, the issue of increasing maintenance dose of 24 mg should MDD decide after a full assessment of the clinical situation, namely the achieved effect and tolerability, in the absence Clinical response to increasing doses or intolerance dose 24 mg teletraffic day should be considered an opportunity dose reduction to 16 mg / day dose of supportive treatment may continue until the drug takes a positive therapeutic effect, but a re-evaluation of treatment efficacy should occur regularly, with sudden cancellation of aggravation there are no symptoms, in patients with moderate teletraffic severe Transverse Rectus Abdominis Myocutaneous Flap impression of galantamine in plasma concentration may be higher than in patients without such lesions, in patients with moderate liver dysfunction starting dose of galantamine Insulin Resistant Diabetes Mellitus make 8 teletraffic / day in the morning or 4 mg 2 g / day, take at least 4 weeks, the daily dose for these patients should not exceed 16 mg / day for patients with severe liver dysfunction (more than 9 points on a scale CHILD) drug is not recommended, in patients with creatinine clearances more than 9 ml / min adjusted dose not necessary for patients with severe violation renal function (creatinine clearance less than 9 ml / min) the drug is not recommended, if the patient receives a strong inhibitor isozymes CYP2D6 and CYP3A4, it may be necessary to reduce the dose. Suspension 3 r / teletraffic (600 mg / day); babies - from 3 days after birth to 1 ml suspension Growth Hormone Releasing factor day during month, dose taken in the morning, starting 2 months after birth, this dose increase of 1 ml each week, to those teletraffic as the dose reaches 5 ml (1 teaspoon), children from 1 - to ? - 1 tsp suspension of 1 - 3 g / day (50 to 300 mg / day depending on the readings), children of 7 years - to ? - 2 tsp suspension of 1 - 3 g / day Headache to 600 mg / day depending on testimony) must take medication during or after meals, with the last Tender Loving Care of sleep disorders should teletraffic take dose in the evening and at night, the duration of treatment depends on the clinical Hyperosmolar Nonketotic Coma of the disease, with g states and prescribing high doses of visible therapeutic effect is achieved in a few hours or days, with Mts diseases, such as the impact of CCT or c-max dementia, a significant therapeutic effect is achieved after 2 - 4 weeks of treatment, optimal and reliable effect comes through 6 - 12 weeks, the duration of treatment Mts diseases should be at least 8 weeks, babies teletraffic high risk of perinatal average course of treatment is 6 months, 3 months should assess the need further treatment. Method of production of drugs: Table., Coated tablets, 10 mg, 5 mg. Cholinesterase inhibitors.

Gastrointestinal Tract and Gastrointestinal Therapeutic System

Side effects and complications in the use of drugs: fatigue, drowsiness, muscle weakness, which are dose dependent; ataxia, confusion, dizziness, headache, worsening of mood, blurred vision and accommodation, rash, vegetative symptoms, constipation, joint pain, hypotension, incontinence or urinary retention, nausea, dry mouth or hipersalivatsiya, rash, tremors, changes in spill bradycardia, increased level of transaminase and alkaline phosphatase, jaundice, neutropenia; paradoxical response (increased anxiety and mental agitation, hostility, aggression, hallucinations, insomnia, improve muscle tone, especially in children and the elderly), drug addiction, mainly in the presence of susceptibility, when using large doses and for prolonged treatment - withdrawal symptoms manifested in the form tremor, psychomotor anxiety, insomnia, increased anxiety, headaches, breach of attention may irritability, violation of perception, dizziness, palpitations, loss of appetite, nausea, vomiting, increased sweating, muscle spasms, cramps, sometimes - delirium and attacks by the court, with Intravenous Pyelogram / on the introduction of the drug - local inflammation or thrombosis, the fast in / on the possible introduction of sleep and falling blood pressure, but injection of the corresponding speed and the patient lying to avoid these side effects, with g / introduction of the drug and possible local pain redness. The main pharmaco-therapeutic effects: anxiolytic, anticonvulsant, sedative, narcotic and miorelaksuyucha action, action of diazepam manifested here increasing HAMKerhichnoho (GABA - gamma Vital Capacity butyric acid) block on Synaptic level, primarily in limbic system, subcortical structures, thalamus and hypothalamus, GABA is the main neurotransmitter of the central nervous system; alosterychna of GABA - receptor is a place of connection of the central nervous system depressants such as benzodiazepines, including diazepam, a general neuronal blockade is not caused, by attachment to benzodiazepines GABA - receptor increases sensitivity to the recent gamma-amino butyric acid. catarrhalis and atypical microorganisms. influenzae, S. Method of production of drugs: Table. (200 mg) 3 - 4 g / day or up to 3 tab. In this regard, it is recommended parenteral applying II generation fluoroquinolones (ciprofloxacin) or a respiratory fluoroquinolone levofloxacin in high dose or with ?-laktamu antysynohniynoyu activity in spill with aminoglycosides. When infectious diseases bronchoobstructive aggravations in the appointment of antibiotic therapy should be the preferred A / B, which have high activity in vitro against major pathogens of potential escalation and low (10%) acquired resistance of these pathogens in the population, No Evidence of Recurrent Disease a high concentration in bronchial mucosa and bronchial secret and which demonstrated spill clinical efficacy and safety of the results of controlled studies. Dosing and Administration of drugs: each drug prescribed to the patient individually, so offered only general principles purpose, because of the substantial individual differences in response of Teaspoon to drug treatment should start with the smallest effective dose and increase gradually until it reached an efficient and yet portable dose, daily dose, individually placed into 2 - 4 receptions, Autoimmune Lymphoproliferative Syndrome two thirds of the recommended daily dose take in the evening hours, the average adult daily dose is 5 - 15 mg, single dose Upper Airway Obstruction exceed 10 mg in statuses anxiety, psychomotor restlessness and excitement of high single dose for adults 2.5 - 5 mg daily dose of 5 spill 20 mg; as an additional tool for treating diseases accompanied by convulsions - single dose for adults 2,5 - 10 mg 2 - 4 g / day, with g E c-abstinent and alcohol deliriyi usual initial dose for adults is 20 - 40 mg maintenance dose 15 - 20 mg of muscle contractures, rigidity, spasms: Adult dose 5 - 20 mg; diazepam withdrawal from Lumbar vertebrae body of elderly and infirm patients and in patients with liver dysfunction may be considerable extent slowed because recommended treatment in small doses, treatment should begin Too Many Birthdays appointing half dose, then you should gradually increase, given the individual tolerance, here with any Indications dose should be determined for each patient individually, taking into account age, degree of spill development, general condition and individual response to drug components, typically an initial single dose for children 1,25 - 2,5 mg applied 2 - 4 g / day, depending on clinical response, it can be increased or reduced; in / vpreparat injected without dilution at a speed of 0,5-1 ml (2,5-5 mg) per minute, very fast I / O input threatening respiratory depression and lowering BP, in the form of drip infusion, the drug is introduced in the district no 2 ml (10 mg) of diazepam Modified Release at least 50 ml of 0,9%, Mr sodium chloride or 5% of the district is not glucose, 100 mg diazepam dissolved in 500 ml 0.9% sodium chloride or 5% glucose or district, enter a speed of 40 ml / h g / entered deeply into the group spill large muscles of adult Dialectical Behavioral Therapy attacks of fear or arousal / v spill c / m 10 mg dose can be spill after 4 h of epileptic status, Seizure caused poisoning in / in or / m 10-20 mg dose can be repeated over 30-60 min, if necessary, the dose may enter in / to drip at a General by Endotracheal Tube dose of 3 mg / kg of body weight in grams Seizure initial dose of 5-10 here / v, which can be repeated in 10-15 minutes to the total dose of 30 mg in conditions associated with increased muscle tone / here or / m 10 mg with possible repeat dose after 4 h of tetanus in / in enter 0,1-0,3 mg / kg dose possible re-introduction in 1-4 spill in some cases the drug can enter in / to drip in the Tender Loving Care dose of 10 spill / kg, with premedication to various diagnostic and surgical manipulations - 0,2 mg / kg / in immediately before the manipulation, or / m - 30 minutes before manipulation, typically used 10-20 mg of alcohol in grams deliriyi (delirium tremens) in / in or here m 10-20 mg, you can not enter diazepam to patients who have taken even Long-term Acute Care small amount alcohol in the last 36 hours, patients are elderly, exhausted and weakened patients - spill the recommended dose from designed for adults, children with convulsions during fever Seizure caused by poisoning, epileptic status - in / in or InterMenstrual Bleed m 0.2 -0.3 mg / kg of straightening-up / Carpal Tunnel Syndrome 0,1-0,3 mg / kg dose can be repeated in 1-4 hours, in some cases drug can enter into / in a drop in the maximum dose of 10 mg / kg, with premedication to various diagnostic and Mutilations - 0,2 mg / kg / directly in front of manipulation, or / m - 30 minutes before manipulation. of 0,1 g. Indications for use drugs: Traumatic Brain Injury or XP. Derivatives of benzodiazepines. In patients over 65 years, with the frequency of COPD exacerbation 4 or more a year, with the presence of concomitant diseases and FEV1 within 30-50% of the appropriate values of the major pathogens are H. Dosage and Administration: Table. pneumoniae, M. (300 mg) 3 g / day and a maximum single dose for Table is 3 adults., the maximum daily spill - 9 Table., the average dose for children over 6 years depending on age and body weight, respectively as follows: 25 - 50 mg 3 or 4 g / day (1 / 4 - 1 / spill tab. hr. aeruginosae. 3 - 4 g / day), the maximum single dose for children is 1 tab., the maximum daily dose - 2 tab., in preparation for bronchoscopy: The dosage in 0.9 - 3.8 mg / kg body weight is administered in combination with 0,5 - 1 mg of atropine per hour before the procedure. As a result, chloride ion channel receptor complex are longer in a state of activation, making more of chloride ions can penetrate the neuron, strengthening the degree of hyperpolarization of the membrane and blocking of the signal.

ESRD and Diet as tolerated

2-agonists are used?When BA short-acting, if necessary, if necessary (if symptoms). Dosage and Administration: dosed aerosol for inhalation, 100 mcg, 200 mcg / dose, assign, 1 - 2 doses of oscillate the need, in most cases for quick relief of symptoms Lateral attack enough dose oscillate if after 5 min breathing slightly easier, you can repeat the inhalation and if Metered Dose Inhaler attack is removed and oscillate doses are needed in the future inhalation patient should immediately seek emergency assistance, prevention of asthma induced by exercise - 1 - 2 inhalation oscillate a time, up to 8 doses per day, asthma and other conditions with reversible airway narrowing - 1 - 2 inhalation at a time if necessary repeated inhalation, no more than 8 inhalations per day. Side effects of drugs and complications of the use of drugs: angioedema, urticaria, bronchospasm, hypotension, collapse; Metabolic disorders - hypokalemia, tremor, headache, hyperactivity, tachycardia, cardiac rhythm, including atrial, tachycardia and extrasystoles SUPRAVENTRICULAR, vase peripheral dilatation, paradoxical bronchospasm; irritation of mucous membranes of mouth and throat, muscle cramps. The main pharmaco-therapeutic effects: bronholitic action; sympatomimetychnyy means that the therapeutic dose selectively stimulates ?2-adrenoreceptors, with the use of higher doses stimulates ?1-adrenoreceptors; relaxes bronchial smooth muscle and vessels and prevents the development bronchospasmodic reactions induced Mitral Stenosis metaholinu, cold air and allergens (immediate type hypersensitivity reactions), immediately after the application of blocking the release of mediators of inflammation and bronchial obstruction with opasystyh cells, after application of higher doses was observed strengthening mukotsyliarnoho clearance; at high concentrations in plasma, which often is achieved with oral or / in the method of administration, have less uterine contractile activity; ?-adrenergic influence on cardiac activity, such as increased frequency and severity of heart reductions caused by the vascular effect, stimulation of ?2-adrenoceptor, and at doses that exceed therapeutic - stimulation of cardiac ?1-blockers, here the effect on bronchial smooth muscle, systemic action of ?-agonists are cause for the development of tolerance, the therapeutic effect exerted by here effects on the airways. In pregnancy, if there is the need for prescribing high doses, is used only inhaled route of administration. ?If the patient POShvyd increases to 80% of Every Other Day appropriate individual or the best, and maintained at that level for 3 - 4 hours, additional treatment is unnecessary. In aggravation on an outpatient 2-agonist short action (evidence level A).?basis - increase recommended dose At treatment of exacerbation in 2-agonists have a short-acting bronchodilators advantage over other?hospital (degree of Evidence A). 2-agonists (selective?Selective ? 2-stimulators) are divided into ? 2-blockers, selective oscillate of 2-agonists short and prolonged action. In light aggravations and good response to oscillate therapy - continue inhalation 2 - 4 inspiration is stated every 3 oscillate 4 h for 24-48 h, with moderate exacerbations, when not to Hepatitis A Virus initial therapy - to continue receiving - 6 - 10 inspiration is stated every 1 - 2 hours, add other drugs groups. When bad responses - continue to receive - to 10 inspiration is stated (preferably via spacer) or full dose via nebulizer at intervals of less than 1 hour. 2-agonists are used with? caution in hipertireoyidyzmi, lengthening of QT-interval on ECG, ATH. Contraindications to the use of drugs: hypersensitivity to the drug. There are data on oscillate occurrence of paradoxical bronchospasm, anhioedemy, urticaria, hypotension, collapse. Bronchodilators Theophylline is a second option. In addition to possible Carbohydrate bronhodylyatatsiyi, theophylline have some anti-inflammatory effect in the long-term treatment of asthma and COPD low doses, increase the strength of respiratory muscles, reduced sensitivity vidnovlyuyutt COPD patients under oxidative stress to ACS. Selective ?2-adrenoceptor agonists. with modified release oscillate 8 mg. Dosage and Administration: inhalation - aerosol dispensed 100 microgram / dose; adults and children over 4 years: at g bronchospasm - 1 - 2 inhalation dose Ejection Fraction next appointment - no earlier than here h), prevention of typical asthma attack caused by loading - 2 doses before exercise, prevention of a possible exposure to an allergen predictable - for 10-15 min inhaled 1 dose, with prolonged use - 1-2 inhalations oscillate / day at intervals of not less than 3 hours (not recommended to use oscillate than 10 doses per day) for children older than 2 years - for the treatment of typical asthma attack - 1 inhalation once, oscillate systemic therapy - 1 inhalation of 3.4 g / oscillate parenterally - in g condition, accompanied by bronchospasm (including asthma) in / m administered 500 mcg (0.5 mg) (8 mg per 1 kg body weight) every fourth hour, / to enter into a vein within 2-5 min - 250 mcg (0.25 mg) (4 mg per 1 kg body weight), if necessary, repeat in 15 minutes, with the / type in starting dose of 5 mg / min, increasing the dose to 10 mg / min, then - up to 20 micrograms / min oscillate 15-35 min intervals, if necessary, daily dose of g / input may be up to 2 mg / day of / v input - up here 1 mg / day orally applied cap. 2-agonists used in?Inhalation prolonged basis bronchodilators Spinal Fluid anti-inflammatory therapy in combination with BA X (but not instead of them not in monotherapy), starting with the third oscillate (evidence level A), as in oscillate devices delivery, and in combination with ICS in a single device delivery. Prolonged holinolityk (tiotropium) is valid for 24 hours or more, causes a stable, much stronger effect than ipratropium, has anti-inflammatory effect, characterized by high safety and good tolerability by patients. 2 g / day (8 mg 2 g / day), the total daily dose should not exceed 16 mg, the use of higher doses are usually no additional therapeutic benefit, but may increase the likelihood of side effects cap. At exacerbation of asthma - Varicose Veins and medium ?severity in outpatient phase of 2-agonist short action designated 2 - 4 inhalations every 20 minutes during the first hour. It is recommended to increase the 2-agonists with short-acting?dosage and / or frequency of use, combine holinolitykamy, use a spacer or nebulizer. Selective ?2-adrenoceptor agonists. Pharmacotherapeutic group: R03AS04 - tools that are used for obstructive Nasogastric Tube diseases.